<DOC>
	<DOCNO>NCT02901977</DOCNO>
	<brief_summary>Randomized double-blind parallel group study patient mild-to-moderate hypertension evaluate effect beyond blood pressure lower effect treatment 12 week ramipril doxazosin hemostatic mechanism endothelial function .</brief_summary>
	<brief_title>Doxazosin Ramipril Hypertension</brief_title>
	<detailed_description>This study aim answer follow question : 1 ) Does antihypertensive therapy doxazosin exhibit antithrombotic effect patient essential hypertension ? 2 ) Are potential antithrombotic effect doxazosin different effect ACE inhibitor ? 3 ) Is relation antihypertensive effect antithrombotic effect antihypertensive agent ? The co-primary outcome change endothelial function assess flow mediate vasodilatation , haemostatic function measure generation thrombin-antithrombin complex .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Primary mildtomoderate hypertension Pregnancy lactation Recent ( 6 month ) malignant disease ongoing treatment malignancy No absolute indication contraindication study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Hemostasis</keyword>
	<keyword>Endothelial function</keyword>
</DOC>